141 related articles for article (PubMed ID: 10637511)
61. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
[TBL] [Abstract][Full Text] [Related]
62. Gene fusions encoding chimaeric transcription factors in solid tumours.
Sorensen PH; Triche TJ
Semin Cancer Biol; 1996 Feb; 7(1):3-14. PubMed ID: 8695764
[TBL] [Abstract][Full Text] [Related]
63. A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited.
Zinszner H; Immanuel D; Yin Y; Liang FX; Ron D
Oncogene; 1997 Jan; 14(4):451-61. PubMed ID: 9053842
[TBL] [Abstract][Full Text] [Related]
64. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.
May WA; Gishizky ML; Lessnick SL; Lunsford LB; Lewis BC; Delattre O; Zucman J; Thomas G; Denny CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5752-6. PubMed ID: 8516324
[TBL] [Abstract][Full Text] [Related]
65. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly.
Pan S; Ming KY; Dunn TA; Li KK; Lee KA
Oncogene; 1998 Mar; 16(12):1625-31. PubMed ID: 9569031
[TBL] [Abstract][Full Text] [Related]
66. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
[TBL] [Abstract][Full Text] [Related]
67. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.
Clark J; Benjamin H; Gill S; Sidhar S; Goodwin G; Crew J; Gusterson BA; Shipley J; Cooper CS
Oncogene; 1996 Jan; 12(2):229-35. PubMed ID: 8570200
[TBL] [Abstract][Full Text] [Related]
68. The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.
Kim S; Lee HJ; Jun HJ; Kim J
Int J Cancer; 2008 Jun; 122(11):2446-53. PubMed ID: 18330902
[TBL] [Abstract][Full Text] [Related]
69. Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins.
Melot T; Gruel N; Doubeikovski A; Sevenet N; Teillaud JL; Delattre O
Hybridoma; 1997 Oct; 16(5):457-64. PubMed ID: 9388029
[TBL] [Abstract][Full Text] [Related]
70. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).
Ichikawa H; Shimizu K; Katsu R; Ohki M
Mol Cell Biol; 1999 Nov; 19(11):7639-50. PubMed ID: 10523652
[TBL] [Abstract][Full Text] [Related]
71. Adenovirus E1A and Ewing tumors.
de Alava E; Sanchez-Prieto R; Ramon Y Cajal S
Nat Med; 2000 Jan; 6(1):4. PubMed ID: 10613795
[No Abstract] [Full Text] [Related]
72. The AF2 domain of the orphan nuclear receptor TEC is essential for the transcriptional activity of the oncogenic fusion protein EWS/TEC.
Maltais A; Filion C; Labelle Y
Cancer Lett; 2002 Sep; 183(1):87-94. PubMed ID: 12049818
[TBL] [Abstract][Full Text] [Related]
73. The TFG-TEC fusion gene created by the t(3;9) translocation in human extraskeletal myxoid chondrosarcomas encodes a more potent transcriptional activator than TEC.
Lim B; Jun HJ; Kim AY; Kim S; Choi J; Kim J
Carcinogenesis; 2012 Aug; 33(8):1450-8. PubMed ID: 22581839
[TBL] [Abstract][Full Text] [Related]
74. The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.
Zhang D; Paley AJ; Childs G
J Biol Chem; 1998 Jul; 273(29):18086-91. PubMed ID: 9660765
[TBL] [Abstract][Full Text] [Related]
75. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts.
Fedele M; Berlingieri MT; Scala S; Chiariotti L; Viglietto G; Rippel V; Bullerdiek J; Santoro M; Fusco A
Oncogene; 1998 Jul; 17(4):413-8. PubMed ID: 9696033
[TBL] [Abstract][Full Text] [Related]
76. Characterization of a new brain-specific isoform of the EWS oncoprotein.
Melot T; Dauphinot L; Sévenet N; Radvanyi F; Delattre O
Eur J Biochem; 2001 Jun; 268(12):3483-9. PubMed ID: 11422378
[TBL] [Abstract][Full Text] [Related]
77. Erythroblast transformation by FLI-1 depends upon its specific DNA binding and transcriptional activation properties.
Ano S; Pereira R; Pironin M; Lesault I; Milley C; Lebigot I; Quang CT; Ghysdael J
J Biol Chem; 2004 Jan; 279(4):2993-3002. PubMed ID: 14570912
[TBL] [Abstract][Full Text] [Related]
78. A functional screening assay for the isolation of transcription factors.
Wiesner C; Hoeth M; Binder BR; de Martin R
Nucleic Acids Res; 2002 Aug; 30(16):e80. PubMed ID: 12177308
[TBL] [Abstract][Full Text] [Related]
79. Mutation in the DNA-binding domain of the EWS-Oct-4 oncogene results in dominant negative activity that interferes with EWS-Oct-4-mediated transactivation.
Kim S; Lee J; Kim JY; Lim B; Shin EK; Han YM; Kim SS; Song JH; Kim J
Int J Cancer; 2009 May; 124(10):2312-22. PubMed ID: 19170206
[TBL] [Abstract][Full Text] [Related]
80. Viral transactivation. Pleiotropy and henchman X.
Gilman M
Nature; 1993 Feb; 361(6414):687-8. PubMed ID: 8441461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
